Highlights Universe Pharmaceuticals INC

Equities

UPC

KYG9442G1120

Market Closed - Nasdaq Other stock markets 21:30:00 31/05/2024 BST			5-day change	1st Jan Change
2.923 ^USD	+9.48%		+21.79%	+45.42%

04-15	Top Premarket Decliners	MT
01-30	Universe Pharmaceuticals INC Reports Earnings Results for the Full Year Ended September 30, 2023	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Universe Pharmaceuticals INC Reports Earnings Results for the Full Year Ended September 30, 2023	01-30	CI
Universe Pharmaceuticals INC Reports Earnings Results for the Half Year Ended March 31, 2023	31/08/23	CI
Universe Pharmaceuticals Receives Nasdaq Non-Compliance Notice	04/08/23	MT
Universe Pharmaceuticals INC Reports Earnings Results for the Full Year Ended September 30, 2022	10/02/23	CI
Universe Pharmaceuticals INC Announces Inclusion of Six Products into the First Edition of Catalogue of Medicine for Patients Infected with COVID-19	21/12/22	CI
Universe Pharmaceuticals INC Reports Earnings Results for the Half Year Ended March 31, 2022	16/08/22	CI
Universe Pharmaceuticals INC Reports Financial Results for The First Six Months of Fiscal Year 2022	16/08/22	PR
Universe Pharmaceuticals INC Announces Strategic Partnership with Lian-Ou Health Pharmaceutical Co., Ltd. to Develop its Digital Marketing and Sales on E-Commerce Platforms	30/03/22	CI
Universe Pharmaceuticals : Annual Report by Foreign Issuer (Form 20-F)	31/01/22	PU
Universe Pharmaceuticals INC Reports Earnings Results for the Full Year Ended September 30, 2021	31/01/22	CI
Universe Pharmaceuticals Partners With Jiangxi Province Institute of Materia Medica to Research Traditional Chinese Medicine	04/01/22	MT
Universe Pharmaceuticals INC Announces Strategic Alliance with Jiangxi Province Institute of Materia Medica to Conduct Research on Traditional Chinese Medicine	04/01/22	CI
Universe Pharmaceuticals INC Announces Strategic Alliance with Jinggangshan University for Study on the Chemical Constituents of Certain Traditional Chinese Medicine	29/12/21	CI
Universe Pharmaceuticals Inc Announces Strategic Alliance with Kitanihon Pharmaceutical Co., Ltd	13/12/21	CI
Universe Pharma to Build Manufacturing, R&D Facility for Chinese Medicine in Deal with Japan's Kitanihon	10/12/21	MT
Universe Pharmaceuticals INC Enters into Definitive Agreements with Kitanihon Pharmaceutical Co., Ltd	10/12/21	CI
Universe Pharmaceuticals : MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION (Form 6-K)	02/08/21	PU
Universe Pharmaceuticals INC Reports Consolidated Unaudited Earnings Results for the Six Months Ended June 30, 2021	02/08/21	CI
Universe Pharmaceuticals : China's Universe Pharmaceuticals Enters Distribution, R&D Partnership With Japan's Kitanihon	25/05/21	MT
Universe Pharmaceuticals INC Enters into Letter of Intent for Strategic Cooperation with Kitanihon Pharmaceutical Co., Ltd	25/05/21	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Universe Pharmaceuticals INC

Equities

UPC

KYG9442G1120

Highlights

Filters